158 related articles for article (PubMed ID: 36982945)
1. Comparing the Effects of Rocaglates on Energy Metabolism and Immune Modulation on Cells of the Human Immune System.
Schiffmann S; Henke M; Seifert M; Ulshöfer T; Roser LA; Magari F; Wendel HG; Grünweller A; Parnham MJ
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982945
[TBL] [Abstract][Full Text] [Related]
2. Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity.
Obermann W; Friedrich A; Madhugiri R; Klemm P; Mengel JP; Hain T; Pleschka S; Wendel HG; Hartmann RK; Schiffmann S; Ziebuhr J; Müller C; Grünweller A
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336926
[TBL] [Abstract][Full Text] [Related]
3. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol.
Müller C; Obermann W; Schulte FW; Lange-Grünweller K; Oestereich L; Elgner F; Glitscher M; Hildt E; Singh K; Wendel HG; Hartmann RK; Ziebuhr J; Grünweller A
Antiviral Res; 2020 Mar; 175():104706. PubMed ID: 31931103
[TBL] [Abstract][Full Text] [Related]
4. Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics.
Taroncher-Oldenburg G; Müller C; Obermann W; Ziebuhr J; Hartmann RK; Grünweller A
Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33807988
[TBL] [Abstract][Full Text] [Related]
5. Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells.
Blum L; Geisslinger G; Parnham MJ; Grünweller A; Schiffmann S
J Cell Mol Med; 2020 Jun; 24(12):6988-6999. PubMed ID: 32374474
[TBL] [Abstract][Full Text] [Related]
6. Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors.
Chu J; Zhang W; Cencic R; Devine WG; Beglov D; Henkel T; Brown LE; Vajda S; Porco JA; Pelletier J
Cell Chem Biol; 2019 Nov; 26(11):1586-1593.e3. PubMed ID: 31519508
[TBL] [Abstract][Full Text] [Related]
7. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.
Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J
Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611
[TBL] [Abstract][Full Text] [Related]
8. A parasitic fungus employs mutated eIF4A to survive on rocaglate-synthesizing
Chen M; Kumakura N; Saito H; Muller R; Nishimoto M; Mito M; Gan P; Ingolia NT; Shirasu K; Ito T; Shichino Y; Iwasaki S
Elife; 2023 Feb; 12():. PubMed ID: 36852480
[TBL] [Abstract][Full Text] [Related]
9. Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication.
Praditya DF; Klöhn M; Brüggemann Y; Brown LE; Porco JA; Zhang W; Kinast V; Kirschning A; Vondran FWR; Todt D; Steinmann E
Antiviral Res; 2022 Aug; 204():105359. PubMed ID: 35728703
[TBL] [Abstract][Full Text] [Related]
10. Broad anti-pathogen potential of DEAD box RNA helicase eIF4A-targeting rocaglates.
Obermann W; Azri MFD; Konopka L; Schmidt N; Magari F; Sherman J; Silva LMR; Hermosilla C; Ludewig AH; Houhou H; Haeberlein S; Luo MY; Häcker I; Schetelig MF; Grevelding CG; Schroeder FC; Lau GSK; Taubert A; Rodriguez A; Heine A; Yeo TC; Grünweller A; Taroncher-Oldenburg G
Sci Rep; 2023 Jun; 13(1):9297. PubMed ID: 37291191
[TBL] [Abstract][Full Text] [Related]
11. The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5' secondary structure.
Svitkin YV; Pause A; Haghighat A; Pyronnet S; Witherell G; Belsham GJ; Sonenberg N
RNA; 2001 Mar; 7(3):382-94. PubMed ID: 11333019
[TBL] [Abstract][Full Text] [Related]
12. Translation Inhibition by Rocaglates Is Independent of eIF4E Phosphorylation Status.
Chu J; Cencic R; Wang W; Porco JA; Pelletier J
Mol Cancer Ther; 2016 Jan; 15(1):136-41. PubMed ID: 26586722
[TBL] [Abstract][Full Text] [Related]
13. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses.
Müller C; Schulte FW; Lange-Grünweller K; Obermann W; Madhugiri R; Pleschka S; Ziebuhr J; Hartmann RK; Grünweller A
Antiviral Res; 2018 Feb; 150():123-129. PubMed ID: 29258862
[TBL] [Abstract][Full Text] [Related]
14. MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells.
Cong Y; Hart BJ; Gross R; Zhou H; Frieman M; Bollinger L; Wada J; Hensley LE; Jahrling PB; Dyall J; Holbrook MR
PLoS One; 2018; 13(3):e0194868. PubMed ID: 29566060
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Zika Virus Replication by Silvestrol.
Elgner F; Sabino C; Basic M; Ploen D; Grünweller A; Hildt E
Viruses; 2018 Mar; 10(4):. PubMed ID: 29584632
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection.
Faure-Dupuy S; Delphin M; Aillot L; Dimier L; Lebossé F; Fresquet J; Parent R; Matter MS; Rivoire M; Bendriss-Vermare N; Salvetti A; Heide D; Flores L; Klumpp K; Lam A; Zoulim F; Heikenwälder M; Durantel D; Lucifora J
J Hepatol; 2019 Dec; 71(6):1086-1098. PubMed ID: 31349000
[TBL] [Abstract][Full Text] [Related]
17. A forward genetic screen identifies modifiers of rocaglate responsiveness.
Shen L; Pugsley L; Cencic R; Wang H; Robert F; Naineni SK; Sahni A; Morin G; Zhang W; Nijnik A; Porco JA; Langlais D; Huang S; Pelletier J
Sci Rep; 2021 Sep; 11(1):18516. PubMed ID: 34531456
[TBL] [Abstract][Full Text] [Related]
18. Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F.
Chu J; Zhang W; Cencic R; O'Connor PBF; Robert F; Devine WG; Selznick A; Henkel T; Merrick WC; Brown LE; Baranov PV; Porco JA; Pelletier J
Cell Rep; 2020 Feb; 30(8):2481-2488.e5. PubMed ID: 32101697
[TBL] [Abstract][Full Text] [Related]
19. The natural compound silvestrol is a potent inhibitor of Ebola virus replication.
Biedenkopf N; Lange-Grünweller K; Schulte FW; Weißer A; Müller C; Becker D; Becker S; Hartmann RK; Grünweller A
Antiviral Res; 2017 Jan; 137():76-81. PubMed ID: 27864075
[TBL] [Abstract][Full Text] [Related]
20. Treatment resistance analysis reveals GLUT-1-mediated glucose uptake as a major target of synthetic rocaglates in cancer cells.
Sieber-Frank J; Stark HJ; Kalteis S; Prigge ES; Köhler R; Andresen C; Henkel T; Casari G; Schubert T; Fischl W; Li-Weber M; Krammer PH; von Knebel Doeberitz M; Kopitz J; Kloor M; Ahadova A
Cancer Med; 2021 Oct; 10(19):6807-6822. PubMed ID: 34546000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]